blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

Italy joins the Federated Register

Click here for more information on the Federated Register.

2025-06-12

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register User Manual
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2445924

EP2445924 - CAPTURE PURIFICATION PROCESSES FOR PROTEINS EXPRESSED IN A NON-MAMMALIAN SYSTEM [Right-click to bookmark this link]
StatusPatent maintained as amended
Status updated on  10.11.2023
Database last updated on 31.03.2026
FormerThe patent has been granted
Status updated on  29.01.2021
FormerGrant of patent is intended
Status updated on  20.09.2020
FormerExamination is in progress
Status updated on  26.02.2019
Most recent event   Tooltip06.09.2024Lapse of the patent in a contracting state
New state(s): MT		published on 09.10.2024  [2024/41]
Applicant(s)For all designated states
Amgen Inc.
One Amgen Center Drive
Thousand Oaks, CA 91320-1799 / US
[2020/47]
Former [2012/18]For all designated states
Amgen, Inc
One Amgen Center Drive
Thousand Oaks, CA 91320-1799 / US
Inventor(s)01 / SHULTZ, Joseph, Edward
11675 Barranca Road
Santa Rosa Valley, CA 93012 / US
02 / HART, Roger
6958 West Country Road 18
Loveland, CO 80537 / US
 [2012/18]
Representative(s)Grünecker Patent- und Rechtsanwälte PartG mbB
Leopoldstraße 4
80802 München / DE
[2021/09]
Former [2012/18]Grünecker, Kinkeldey, Stockmair & Schwanhäusser
Leopoldstrasse 4
80802 München / DE
Application number, filing date10729997.624.06.2010
[2021/09]
WO2010US39854
Priority number, dateUS20090220477P25.06.2009         Original published format: US 220477 P
[2012/18]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2010151688
Date:29.12.2010
Language:EN
[2010/52]
Type: A2 Application without search report 
No.:EP2445924
Date:02.05.2012
Language:EN
The application published by WIPO in one of the EPO official languages on 29.12.2010 takes the place of the publication of the European patent application.
[2012/18]
Type: B1 Patent specification 
No.:EP2445924
Date:03.03.2021
Language:EN
[2021/09]
Type: B2 New European patent specification 
No.:EP2445924
Date:13.12.2023
Language:EN
[2023/50]
Search report(s)International search report - published on:EP19.05.2011
ClassificationIPC:C07K1/22, C07K1/32, C07K1/18, C07K1/14
[2020/42]
CPC:
C07K1/22 (EP,US); C07K1/145 (EP,US); C07K1/18 (EP,US);
C07K1/32 (EP,US); C07K16/00 (US)
Former IPC [2012/18]C07K1/22, C07K1/32, C07K1/18
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   SM,   TR [2012/18]
Extension statesBA25.01.2012
ME25.01.2012
RS25.01.2012
TitleGerman:VEFAHREN ZUR AUFREINIGUNG VON PROTEINEN AUS PROKARYOTISCHEN ZELLEN[2020/42]
English:CAPTURE PURIFICATION PROCESSES FOR PROTEINS EXPRESSED IN A NON-MAMMALIAN SYSTEM[2012/18]
French:PROCÉDÉS DE PURIFICATION PAR CAPTURE DE PROTÉINES EXPRIMÉES DANS UN SYSTÈME NON MAMMIFÈRE[2012/18]
Former [2012/18]DIREKTES EINFANG- UND AUFREINIGUNGSVERFAHREN FÜR IN EINEM NICHTSÄUGERSYSTEM EXPRIMIERTE PROTEINE
Entry into regional phase25.01.2012National basic fee paid 
25.01.2012Designation fee(s) paid 
25.01.2012Examination fee paid 
Examination procedure25.01.2012Amendment by applicant (claims and/or description)
25.01.2012Examination requested  [2012/18]
11.09.2015Despatch of a communication from the examining division (Time limit: M06)
21.03.2016Reply to a communication from the examining division
01.03.2019Despatch of a communication from the examining division (Time limit: M06)
11.09.2019Reply to a communication from the examining division
28.01.2020Despatch of a communication from the examining division (Time limit: M04)
19.05.2020Reply to a communication from the examining division
21.09.2020Communication of intention to grant the patent
26.01.2021Fee for grant paid
26.01.2021Fee for publishing/printing paid
26.01.2021Receipt of the translation of the claim(s)
Divisional application(s)EP19209054.6  / EP3660032
The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  11.09.2015
Opposition(s)Opponent(s)01  03.12.2021  07.12.2021  ADMISSIBLE
Neuefeind, Regina
Maiwald GmbH
Elisenhof
Elisenstraße 3
80335 München / DE
Opponent's representative
Maiwald GmbH
Elisenhof
Elisenstraße 3
80335 München / DE
 [2023/04]
Former [2022/02]
Opponent(s)01  03.12.2021  07.12.2021  ADMISSIBLE
Neuefeind, Regina
Maiwald Patentanwalts - und
Rechtsanwaltsgesellschaft mbH
Elisenhof
Elisenstraße 3
80335 München / DE
Opponent's representative
Neuefeind, Regina
Maiwald Patentanwalts- und
Rechtsanwaltsgesellschaft mbH
Elisenhof
Elisenstraße 3
80335 München / DE
17.12.2021Invitation to proprietor to file observations on the notice of opposition
27.04.2022Reply of patent proprietor to notice(s) of opposition
12.04.2023Date of oral proceedings
08.05.2023Despatch of interlocutory decision in opposition
08.05.2023Despatch of minutes of oral proceedings
12.09.2023Legal effect of interlocutory decision in opposition
28.09.2023Despatch of communication that the patent will be maintained as amended
08.11.2023Fee for printing new specification paid
Appeal following opposition18.07.2023Appeal received No.  T1504/23
18.07.2023Payment of appeal fee
12.09.2023Result of appeal procedure: appeal of the proprietor withdrawn
Fees paidRenewal fee
14.06.2012Renewal fee patent year 03
10.06.2013Renewal fee patent year 04
12.06.2014Renewal fee patent year 05
10.06.2015Renewal fee patent year 06
10.06.2016Renewal fee patent year 07
16.06.2017Renewal fee patent year 08
12.06.2018Renewal fee patent year 09
13.06.2019Renewal fee patent year 10
15.06.2020Renewal fee patent year 11
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU24.06.2010
AL03.03.2021
AT03.03.2021
CY03.03.2021
CZ03.03.2021
DK03.03.2021
EE03.03.2021
FI03.03.2021
HR03.03.2021
LT03.03.2021
LV03.03.2021
MC03.03.2021
MK03.03.2021
MT03.03.2021
PL03.03.2021
RO03.03.2021
SE03.03.2021
SI03.03.2021
SK03.03.2021
SM03.03.2021
TR03.03.2021
BG03.06.2021
NO03.06.2021
GR04.06.2021
IE24.06.2021
LU24.06.2021
BE30.06.2021
IS03.07.2021
PT05.07.2021
[2024/41]
Former [2024/29]HU24.06.2010
AL03.03.2021
AT03.03.2021
CY03.03.2021
CZ03.03.2021
DK03.03.2021
EE03.03.2021
FI03.03.2021
HR03.03.2021
LT03.03.2021
LV03.03.2021
MC03.03.2021
MK03.03.2021
PL03.03.2021
RO03.03.2021
SE03.03.2021
SI03.03.2021
SK03.03.2021
SM03.03.2021
TR03.03.2021
BG03.06.2021
NO03.06.2021
GR04.06.2021
IE24.06.2021
LU24.06.2021
BE30.06.2021
IS03.07.2021
PT05.07.2021
Former [2024/22]HU24.06.2010
AL03.03.2021
AT03.03.2021
CY03.03.2021
CZ03.03.2021
DK03.03.2021
EE03.03.2021
FI03.03.2021
HR03.03.2021
LT03.03.2021
LV03.03.2021
MC03.03.2021
MK03.03.2021
PL03.03.2021
RO03.03.2021
SE03.03.2021
SI03.03.2021
SK03.03.2021
SM03.03.2021
BG03.06.2021
NO03.06.2021
GR04.06.2021
IE24.06.2021
LU24.06.2021
BE30.06.2021
IS03.07.2021
PT05.07.2021
Former [2023/29]HU24.06.2010
AL03.03.2021
AT03.03.2021
CY03.03.2021
CZ03.03.2021
DK03.03.2021
EE03.03.2021
FI03.03.2021
HR03.03.2021
LT03.03.2021
LV03.03.2021
MC03.03.2021
PL03.03.2021
RO03.03.2021
SE03.03.2021
SI03.03.2021
SK03.03.2021
SM03.03.2021
BG03.06.2021
NO03.06.2021
GR04.06.2021
IE24.06.2021
LU24.06.2021
BE30.06.2021
IS03.07.2021
PT05.07.2021
Former [2023/24]AL03.03.2021
AT03.03.2021
CY03.03.2021
CZ03.03.2021
DK03.03.2021
EE03.03.2021
FI03.03.2021
HR03.03.2021
LT03.03.2021
LV03.03.2021
MC03.03.2021
PL03.03.2021
RO03.03.2021
SE03.03.2021
SI03.03.2021
SK03.03.2021
SM03.03.2021
BG03.06.2021
NO03.06.2021
GR04.06.2021
IE24.06.2021
LU24.06.2021
BE30.06.2021
IS03.07.2021
PT05.07.2021
Former [2022/34]AL03.03.2021
AT03.03.2021
CZ03.03.2021
DK03.03.2021
EE03.03.2021
FI03.03.2021
HR03.03.2021
LT03.03.2021
LV03.03.2021
MC03.03.2021
PL03.03.2021
RO03.03.2021
SE03.03.2021
SI03.03.2021
SK03.03.2021
SM03.03.2021
BG03.06.2021
NO03.06.2021
GR04.06.2021
IE24.06.2021
LU24.06.2021
BE30.06.2021
IS03.07.2021
PT05.07.2021
Former [2022/23]AL03.03.2021
AT03.03.2021
CZ03.03.2021
DK03.03.2021
EE03.03.2021
FI03.03.2021
HR03.03.2021
LT03.03.2021
LV03.03.2021
MC03.03.2021
PL03.03.2021
RO03.03.2021
SE03.03.2021
SI03.03.2021
SK03.03.2021
SM03.03.2021
BG03.06.2021
NO03.06.2021
GR04.06.2021
IE24.06.2021
LU24.06.2021
IS03.07.2021
PT05.07.2021
Former [2022/21]AL03.03.2021
AT03.03.2021
CZ03.03.2021
DK03.03.2021
EE03.03.2021
FI03.03.2021
HR03.03.2021
LT03.03.2021
LV03.03.2021
MC03.03.2021
PL03.03.2021
RO03.03.2021
SE03.03.2021
SI03.03.2021
SK03.03.2021
SM03.03.2021
BG03.06.2021
NO03.06.2021
GR04.06.2021
IE24.06.2021
LU24.06.2021
PT05.07.2021
IS23.12.2021
Former [2022/18]AL03.03.2021
AT03.03.2021
CZ03.03.2021
DK03.03.2021
EE03.03.2021
FI03.03.2021
HR03.03.2021
LT03.03.2021
LV03.03.2021
MC03.03.2021
PL03.03.2021
RO03.03.2021
SE03.03.2021
SI03.03.2021
SK03.03.2021
SM03.03.2021
BG03.06.2021
NO03.06.2021
GR04.06.2021
LU24.06.2021
PT05.07.2021
IS23.12.2021
Former [2022/13]AL03.03.2021
AT03.03.2021
CZ03.03.2021
DK03.03.2021
EE03.03.2021
FI03.03.2021
HR03.03.2021
LT03.03.2021
LV03.03.2021
MC03.03.2021
PL03.03.2021
RO03.03.2021
SE03.03.2021
SI03.03.2021
SK03.03.2021
SM03.03.2021
BG03.06.2021
NO03.06.2021
GR04.06.2021
PT05.07.2021
IS23.12.2021
Former [2022/10]AL03.03.2021
AT03.03.2021
CZ03.03.2021
DK03.03.2021
EE03.03.2021
FI03.03.2021
HR03.03.2021
LT03.03.2021
LV03.03.2021
MC03.03.2021
PL03.03.2021
RO03.03.2021
SE03.03.2021
SK03.03.2021
SM03.03.2021
BG03.06.2021
NO03.06.2021
GR04.06.2021
PT05.07.2021
IS23.12.2021
Former [2022/08]AL03.03.2021
AT03.03.2021
CZ03.03.2021
DK03.03.2021
EE03.03.2021
FI03.03.2021
HR03.03.2021
LT03.03.2021
LV03.03.2021
MC03.03.2021
PL03.03.2021
RO03.03.2021
SE03.03.2021
SK03.03.2021
SM03.03.2021
BG03.06.2021
NO03.06.2021
GR04.06.2021
IS03.07.2021
PT05.07.2021
Former [2022/07]AL03.03.2021
AT03.03.2021
CZ03.03.2021
EE03.03.2021
FI03.03.2021
HR03.03.2021
LT03.03.2021
LV03.03.2021
MC03.03.2021
PL03.03.2021
RO03.03.2021
SE03.03.2021
SK03.03.2021
SM03.03.2021
BG03.06.2021
NO03.06.2021
GR04.06.2021
IS03.07.2021
PT05.07.2021
Former [2021/51]AT03.03.2021
CZ03.03.2021
EE03.03.2021
FI03.03.2021
HR03.03.2021
LT03.03.2021
LV03.03.2021
PL03.03.2021
RO03.03.2021
SE03.03.2021
SK03.03.2021
SM03.03.2021
BG03.06.2021
NO03.06.2021
GR04.06.2021
IS03.07.2021
PT05.07.2021
Former [2021/50]AT03.03.2021
CZ03.03.2021
EE03.03.2021
FI03.03.2021
HR03.03.2021
LT03.03.2021
LV03.03.2021
PL03.03.2021
RO03.03.2021
SE03.03.2021
SK03.03.2021
SM03.03.2021
BG03.06.2021
NO03.06.2021
GR04.06.2021
PT05.07.2021
Former [2021/48]AT03.03.2021
CZ03.03.2021
EE03.03.2021
FI03.03.2021
HR03.03.2021
LT03.03.2021
LV03.03.2021
PL03.03.2021
SE03.03.2021
SM03.03.2021
BG03.06.2021
NO03.06.2021
GR04.06.2021
Former [2021/46]AT03.03.2021
FI03.03.2021
HR03.03.2021
LT03.03.2021
LV03.03.2021
PL03.03.2021
SE03.03.2021
SM03.03.2021
BG03.06.2021
NO03.06.2021
GR04.06.2021
Former [2021/39]FI03.03.2021
HR03.03.2021
LT03.03.2021
LV03.03.2021
PL03.03.2021
SE03.03.2021
BG03.06.2021
NO03.06.2021
GR04.06.2021
Former [2021/38]FI03.03.2021
HR03.03.2021
LT03.03.2021
LV03.03.2021
SE03.03.2021
BG03.06.2021
NO03.06.2021
GR04.06.2021
Former [2021/37]FI03.03.2021
HR03.03.2021
LT03.03.2021
LV03.03.2021
BG03.06.2021
NO03.06.2021
GR04.06.2021
Former [2021/36]FI03.03.2021
HR03.03.2021
LT03.03.2021
BG03.06.2021
NO03.06.2021
GR04.06.2021
Former [2021/35]FI03.03.2021
HR03.03.2021
LT03.03.2021
NO03.06.2021
Former [2021/33]FI03.03.2021
LT03.03.2021
NO03.06.2021
Cited inInternational search[XY] DE102005033250  (BIOCEUTICALS ARZNEIMITTEL AG et al.)
 [I] US5466377  (GRANDICS PETER et al.)
 [XI]   ARVIDSSON P ET AL: "Direct chromatographic capture of enzyme from crude homogenate using immobilized metal affinity chromatography on a continuous supermacroporous adsorbent", JOURNAL OF CHROMATOGRAPHY, ELSEVIER SCIENCE PUBLISHERS B.V, NL, vol. 986, no. 2, 7 February 2003 (2003-02-07), pages 275 - 290, XP004402803, ISSN: 0021-9673, DOI: 10.1016/S0021-9673(02)01871-X

DOI:   http://dx.doi.org/10.1016/S0021-9673(02)01871-X
 [XI]   LING ET AL: "Integration of mechanical cell disruption and fluidised bed recovery of G3PDH from unclarified disrupted yeast: A comparative study of the performance of unshielded and polymer shielded dye-ligand chromatography systems", JOURNAL OF BIOTECHNOLOGY, ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL, vol. 119, no. 4, 10 October 2005 (2005-10-10), pages 436 - 448, XP005082662, ISSN: 0168-1656, DOI: 10.1016/J.JBIOTEC.2005.05.029

DOI:   http://dx.doi.org/10.1016/j.jbiotec.2005.05.029
 [Y]   FISCHER B ET AL: "ISOLATION, RENATURATION, AND FORMATION OF DISULFIDE BONDS OF EUKARYOTIC PROTEINS EXPRESSED IN ESCHERICHIA COLI AS INCLUSION BODIES", BIOTECHNOLOGY AND BIOENGINEERING, WILEY & SONS, HOBOKEN, NJ, US, vol. 41, no. 1, 5 January 1993 (1993-01-05), pages 3 - 13, XP000605146, ISSN: 0006-3592, DOI: 10.1002/BIT.260410103

DOI:   http://dx.doi.org/10.1002/bit.260410103
Examination  RONNMARK J ET AL: "Construction and characterization of affibody-Fc chimeras produced in Escherichia coli", JOURNAL OF IMMUNOLOGICAL METH, ELSEVIER SCIENCE PUBLISHERS B.V.,AMSTERDAM, NL, vol. 261, no. 1-2, 1 March 2002 (2002-03-01), pages 199 - 211, XP004341280, ISSN: 0022-1759, DOI: 10.1016/S0022-1759(01)00563-4

DOI:   http://dx.doi.org/10.1016/S0022-1759(01)00563-4
by applicantUS61220477
 US6660843
 US7138370
 US7511012
   SHUKLA ET AL., JOURNAL OF CHROMATOGRAPHY B, vol. 848, no. 1, 2007, pages 28 - 39
   WANG ET AL., BIOCHEM. J., vol. 325, 1997, pages 707 - 710
   WANG ET AL., BIOCHEMICAL JOURNAL, vol. 325, 1997, pages 707 - 710
   DEVEREUX ET AL., NUCL. ACIDS RES., vol. 12, 1984, pages 387
   GRIBSKOV; BURGESS, NUCL. ACIDS RES., vol. 14, 1986, pages 6745
   OSTROVE: "Guide to Protein Purification", METHODS IN ENZYMOLOGY, vol. 182, 1990, pages 357 - 379
   WANG ET AL., BIOCHEM. J., vol. 325, no. 3, 1997, pages 707 - 710
   VOLA ET AL., CELL BIOPHYS., vol. 24-25, 1994, pages 27 - 36
   AYBAY; IMIR, J. IMMUNOL. METHODS, vol. 233, no. 1-2, 2000, pages 77 - 81
   FORD ET AL., J. CHROMATOGR. B, vol. 754, 2001, pages 427 - 435
   EJIMA ET AL., ANALYTICAL BIOCHEMISTRV, vol. 345, no. 2, 2005, pages 250 - 257
   ARAKAWA ET AL., PROTEIN EXPRESSION & PURIFICATION, vol. 36, no. 2, 2004, pages 244 - 248
   MILLER; STONE, J. IMMUNOL. METHODS, vol. 24, no. 1-2, 1978, pages 111 - 125
   STOSCHEK: "Quantitation of Protein", "GUIDE TO PROTEIN PURIFICATION," METHODS IN ENZYMOLOGY, vol. 182, 1990, pages 50 - 68
OppositionWO2006036834
 WO2007022070
 WO2009107129
 WO2006047340
 WO2006036834
 WO2007022070
 WO2009107129
   FISHER, S.M. TRAIL, D. HECHT, R.I.: "The high throughput purification of Fc-fusion proteins", PROCESS BIOCHEMISTRY, ELSEVIER LTD, GB, vol. 41, no. 12, 1 December 2006 (2006-12-01), GB , pages 2473 - 2476, XP005717899, ISSN: 1359-5113, DOI: 10.1016/j.procbio.2006.06.010

DOI:   http://dx.doi.org/10.1016/j.procbio.2006.06.010
   ANONYMOUS: "GE Healthcare Data File 11-0034-90 AC HiTrap MabSelect SuRe, HiTrap MabSelect, HiTrap MabSelect Xtra", UPPSALA, 1 June 2007 (2007-06-01), Uppsala , pages 1 - 8, XP055519138, Retrieved from the Internet [retrieved on 20181025]
   CLARK E D B: "Protein refolding for industrial processes.", CURRENT OPINION IN BIOTECHNOLOGY, LONDON, GB, vol. 12, no. 2, 1 April 2001 (2001-04-01), GB , pages 202 - 207, XP002485975, ISSN: 0958-1669, DOI: 10.1016/S0958-1669(00)00200-7

DOI:   http://dx.doi.org/10.1016/S0958-1669(00)00200-7
   RUDOLPH R., LILIE H.: "IN VITRO FOLDING OF INCLUSION BODY PROTEINS.", THE FASEB JOURNAL, FEDERATION OF AMERICAN SOCIETIES FOR EXPERIMENTAL BIOLOGY, US, vol. 10., no. 01., 1 January 1996 (1996-01-01), US, pages 49 - 56., XP000605154, ISSN: 0892-6638
   BERNARDEZ CLARK DE E, SCHWARZ E, RUDOLPH R: "INHIBITION OF AGGREGATION SIDE REACTIONS DURING IN VITRO PROTEIN FOLDING", BIOMEMBRANES: TRANSPORT THEORY : CELLS AND MODEL MEMBRANES, ELSEVIER, ACADEMIC PRESS, NL, vol. 309, 1 January 1999 (1999-01-01), NL , pages 217 - 236, XP001106196, ISBN: 978-0-12-805382-9, DOI: 10.1016/S0076-6879(99)09017-5

DOI:   http://dx.doi.org/10.1016/S0076-6879(99)09017-5
   ANONYMOUS: "MEP HyperCel product information sheet ", BIOSEPRA, 1 July 2000 (2000-07-01), XP055912261, [retrieved on 20220413]
   FAHRNER R L, ET AL: "Industrial Purification of Pharmaceutical Antibodies: Development, Operation, and Validation of Chromatography Processes", BIOTECHNOLOGY AND GENETIC ENGINEERING REVIEWS, INTERCEPT LTD., ANDOVER, GB, vol. 18, no. 12, 1 July 2001 (2001-07-01), GB , pages I - 301-327, XP003035628, ISSN: 0264-8725, DOI: 10.1080/02648725.2001.10648017

DOI:   http://dx.doi.org/10.1080/02648725.2001.10648017
   ANONYMOUS: "Mab Select Sure product information sheet", GE HEALTHCARE, 1 September 2007 (2007-09-01), XP055912264, [retrieved on 20220413]
   LUTE ET AL., JOURNAL OF CHROMATOGRAPHY A, vol. 1205, 2008, pages 17 - 25, XP025348191

DOI:   http://dx.doi.org/10.1016/j.chroma.2008.07.094
   FISHER ET AL: "The high throughput purification of Fc-fusion proteins", PROCESS BIOCHEMISTRY, vol. 41, no. 12, 1 December 2006 (2006-12-01), GB , pages 2473 - 2476, ISSN: 1359-5113, DOI: 10.1016/j.procbio.2006.06.010
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.